Bing

The U.S. Food and Drug Administration (FDA) declined to approve Northera, CHTP’s blood pressure treatment, in 2012. CHTP resubmitted the drug in September. A research note from analysts at Wedbush indicated that an FDA advisory panel recently …
Investor Place · ByChristopher Freeburn · 1/16/2014
This reverses the recent trend for CHTP, as the stock is now up over 12% since Jan 15. This pharmaceutical company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings …
Yahoo Finance · 2/14/2014
After Rockwell Medical Inc (NASDAQ:RMTI) stock was lifted to Buy and price target $22 at Chardan Capital Markets. Rockwell Medical Inc (NASDAQ:RMTI) shares rose 5.99%, to end at $11.15. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) …
fxnewscall.com · 12/20/2013
More from Bing News
I have screened these 5 biotechnology stocks based on the following criteria: 1. Chelsea Therapeutics International Ltd (NASDAQ:CHTP): Chelsea Therapeutics is a development stage pharmaceutical company that focuses on acquiring, developing and ...
Seeking Alpha · 5/11/2012
11/13/2013 - Growing Stock Report initiates its NASDAQ Active Stock Weekly Watch List adding Breitburn Energy Partners L.P. BBEP, -14.23% Chelsea Therapeutics International Ltd. CHTP xG Technology, Inc. XGTI, +2.25% and Synta Pharmaceuticals …
Market Watch · 11/13/2013
... target for multiple pharmaceutical companies because of the approval of Northera The stock price of Chelsea Therapeutics International Ltd. (CHTP) is soaring by more than 14% to $5.95 per share at the time of this writing around 1:56 in the afternoon ...
The Street · 3/15/2014
Chelsea Therapeutics International Ltd. ( CHTP) saw a big move last session, as the company's shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the …
NASDAQ · 2/14/2014
In recent days here, we’ve been talking about ways you can turn this correction – if that’s what it is – to your personal advantage. So we’ve been looking at stocks and strategies that will help you achieve that goal.
Money Morning · 1/18/2014
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) is definitely the soapiest soap opera of biopharma. It’s virtually impossible to keep track of the multiple trials, the changing endpoints mid-trial, the dubious and equivocal trial results, the ...
INSIDER MONKEY · 3/15/2013
Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... Click Here Now Chelsea's (NASDAQ: CHTP ) Northera, a blood pressure boosting treatment designed to help prevent fainting, finally got the FDA's go-ahead after taking ...
The Motley Fool · 2/22/2014